Zhende Medical(SH:603301) Sou Hu Cai Jing·2025-11-06 00:21Core Viewpoint - Zhendemedical (603301) experienced a significant increase in stock price, closing at 99.94 yuan on November 5, 2025, with a rise of 5.54% and a trading volume of 20.49 million shares, indicating strong market interest [1][2]. Financial Performance - For the first three quarters of 2025, Zhendemedical reported a main business revenue of 3.184 billion yuan, a year-on-year increase of 1.88%, while the net profit attributable to shareholders was 203 million yuan, a decline of 33.91% [5]. - In Q3 2025, the company achieved a single-quarter main business revenue of 1.084 billion yuan, a slight increase of 0.1% year-on-year, but the net profit attributable to shareholders fell by 48.47% to 75.42 million yuan [5]. Market Activity - On November 5, 2025, the net inflow of main funds was 169 million yuan, accounting for 8.45% of the total trading volume, while retail investors saw a net outflow of 153 million yuan, representing 7.62% of the total [1][2]. - The financing data indicated a net repayment of 14.08 million yuan on the same day, with a financing balance of 1.218 billion yuan [3]. Industry Comparison - Zhendemedical's total market capitalization is 26.629 billion yuan, significantly higher than the industry average of 11.527 billion yuan, ranking 8th out of 124 in the medical device sector [5]. - The company's net profit margin stands at 6.61%, below the industry average of 9.57%, and its gross margin is 33.93%, compared to the industry average of 51.22% [5]. Institutional Ratings - In the past 90 days, two institutions have given a buy rating for Zhendemedical, with an average target price of 58.0 yuan [6].